How effective is follow-up after cancer treatment for smouldering myeloma?

Smouldering myeloma may remain stable for a long time or develop features that need a different treatment plan. Follow-up gives the care team repeated opportunities to compare blood results, urine findings, symptoms, and sometimes imaging. The pattern over time matters more than one isolated result. Reviews can look for rising abnormal proteins, changes in blood counts, kidney function, calcium, or bone-related symptoms. These checks help distinguish continued observation from a need for further assessment. Surveillance is therefore a monitoring strategy, not a promise that progression will be prevented.

Keep scheduled haematology appointments and complete the requested blood or urine tests before each review. Bring a list of new symptoms, medicines, supplements, and questions. Tell the team about persistent back or bone pain, unusual tiredness, repeated infections, increased thirst, changes in urination, or unexpected weight change. Ask which results are being followed and what change would lead to imaging, a closer review, or treatment. Keep copies of reports if you see more than one specialist, so results can be compared accurately.

Contact your oncology or haematology team promptly for new or worsening bone pain, weakness, numbness, confusion, marked thirst, reduced urine, fever, or an infection that is difficult to control. Sudden severe back pain with leg weakness or loss of bladder or bowel control needs urgent medical attention. Do not wait for the next routine surveillance visit when symptoms are severe or rapidly changing.

Which blood and urine markers will we compare at each visit? What symptoms should change the timing of my next review? When would you recommend imaging or a bone marrow assessment? How will you explain a result that changes slightly but does not clearly show progression?